Adrenergic Agonists.

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
PHARMACOLOGY OF SNS.
Pharmacology-1 PHL 211 Fourteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
SYMPATHETIC NERVOUS SYTEM
Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode.
ADRENERGIC ANTAGONITS
Autonomic Nervous System
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic Agonists (Sympathomimetics)
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors  Alpha-(α-) adrenergic receptors,
Sympathomimetics (continue)
SYMPATHOMIMETIC DRUGS
SYMPATHOMIMETICS Classification: A- According to the source:
Vasopressors.
Adrenergic agonists Samuel Aguazim (MD).
AUTONOMIC SYSTEMS AND DRUGS-2
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Synthesis & Release of Neurotransmitters
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
1 A N S  NERVOUS SYSTEM  PNS CNS   EFFERENT AFFERENT   ANS SOMATIC  ENTERIC  PARASYMPATHETIC  SYMPATHETIC.
Adrenergic Agonists Prof. A. Alhaider. Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC.
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Sympathomimetic Agents
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Actions of epinephrine:
Lecture 11b Clinical uses of adrenergic agonists.
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
Sympathomimetics Review 28 February :25 PM.
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Drug action on Sympathetic Nerves: No. 3: Sympatholytic drugs
SYMPATHOMIMETIC AGENTS
Adrenergic Agonists and Adrenergic Blockers
Adrenergic Agonists.
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
على قدر الهدف يكون الانطلاق.
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Adrenergic agonist: PHARMACOLOGY OF SNS.
Adrenergic Agonists Produce their effects by activating adrenergic receptors Adrenergic receptors are Alpha 1 Alpha 2 Beta 1 Beta 2 Dopamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic drugs.
Pharmacological actions of cathecholamines
Type of adrenergic receptor
Sympathomimetics Domina Petric, MD.
School of Pharmacy, University of Nizwa
Chapter 5 Autonomic Drugs.
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Adrenergic [ædrə‘nədʒik] agonists
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic Agonists.
Adrenergic agonists and antagonists
Sympathomimetics or Adrenergic Drugs
Adrenergic agonists ILOS
Adrenergic Antagonists
Presentation transcript:

Adrenergic Agonists

Sympathetic Nervous System Adrenalin, Noradrenalin Sympathomimetics (direct & indirect) Sympatholytics Adrenergic Receptors

Removal of Norepinephrine Diffuse out of the synaptic cleft Metabolized by COMT Reuptake into the neuron Tricyclic antidepressants (TCA, imipramine) Serotonin-NE reuptake inhibitors (duloxetine) Cocaine Fate of NE /taken up by vesicles/amine transporter system Release Protected pools Oxidized by MAO

Adrenergic Receptors

α-receptors Epinephrine ≥ NE >> isoproterenol α1 Receptors postsynaptic Constriction of SM Gptn-coupled Rs (phospholipase C) α 2 Receptors inhibitory autoreceptos inhibitory heterreceptors Inhibition of adenylyl cyclase Subdivisions α1A, α1B, α1C, α1D---------Tamsulosin α2A, α2B, α2C

β-adrenergic Receptors Isoproterenol > epinephrine > NE Β1, β 2, β3: Β1 epinephrine = NE Β2: epinephrine >> NE Activation of adenylyl cyclase SkM vasculature β2 >> β1 Myocardium β1 >>>> β2 Responses of adrenergic Rs

Desensitization of Receptors Sequestration of Rs Down-regulation Inability to couple G ptn

Adrenergic Agonists A-Catecholamine B-Non-catecholamine C-Mixed-acting agonist

Epinephrine Direct acting Naturally occurring neurotransmitter Adrenal medulla (80% Epi, 20% NE) α & β At low dose β (vasodilation) At high doses α (vasoconstriction)

Epinephrine- CVS +ve inotropic (β1) +ve chronotropic (β1) CO is increased Oxygen demand is increased β1 in Kidneys---renin release---angiotensin II---??? α in arterioles in skin---??? β 2 vessels going to liver & SkMs---??? Renal BF is decreased Cumulative effect is increased sys BP & slight decrease in dias. BP

Respiratory Liver Adipose tissues Bronchodilation β 2 Epinephrine- cont. Respiratory Bronchodilation β 2 Inhibit release of allergy mediators e.g. histamine from mast cells Liver Hyperglycemia due to increased glycogenolysis ??? Increased glucagon release ??? Decreased insulin release ??? Adipose tissues Increased lipolysis ??? Increased cAMP --- hormone sensitive lipase ---hydrolyze TG to FFA & glycerol

Therapeutic Uses of Epinephrine Bronchospasm Drug of choice in acute asthma & anaphylactic shock Selective β2 agonists are preferred in chronic asthma (albuterol) Anaphylactic shocks Cardiac arrest Anesthetics (1: 100 000)

Pharmacokinetics Adverse effects Rapid onset, short duration IM, IV, SC, inhalation, endotracheal intubation MAO, COMT---metanephrine, VMA Adverse effects CNS (anxiety, fear, tension, headache & tremor Cardiac arrhythmias Pulmonary edema CVS / hyperthyroidismm Inhalation / tachycardia Increase endogenous glucoses--- diabetes Non-selective β-blockers???

Norepinephrine CVS Increase peripheral resistance Increase syst. & diast. BP Weak β2 activity Baroreceptor reflex (chronotropic effect) Atropine + NE ??? Therapeutic uses ----- shock Kinetics: IV, short duration of action, metabolized by COMT & MAO, excreted in urine Adverse effects: blanching & sloughing of skin, T necrosis (extravasation) Antagonized by phentolamine

Isoproterenol Direct acting, synthetic Stimulates both β1 & β2, nonselective Insignificant α effects + ve chronotropic & inotropic effect, increase HR & CO Decrease PR ???? Syst. P increased ??? Diast. P decreased ????, Mean Arterial P??? Bronchodilator ??? Used in AV block

Dopamine Metabolic precursor to NE CNS (basal ganglia) and adrenal medulla High dose ----vasoconstriction Low doses ----- cardiac stimulation (+ve inotropic & chronotropic) D1 D2 Rs (peripheral mesenteric & renal vascular bed)----??? Presynaptic D2 Rs -----???

Dopamine, cont Therapeutic uses: D of choice in cardiogenic & septic shock (contin. infusion) & superior to NE????? Used for hypotension & severe HF Adverse effects: Sympathetic stimulation Rapid metabolism with COMT, MAO Nausea, hypertension & arrhythmia

Fenoldopam Agonist for peripheral D1 Used in severe hypertension (coronary arteries, kid. Arterioles, mesenteric arteries) R isomer is active Extensive 1st pass effect (te1/2=10min after IV infusion) Headache, flushing, dizziness, vomiting & tachycardia

Dobutamine Synthetic, direct acting catecholamine, direct β1 effect Increases HR & CO without effect on O2 demand Used with caution in atrial fibrillation ??? Tolerance may develop

Oxymetazoline Direct acting, synthetic cpd Act on α1 & α2 In OTC as nasal spray & ophthalmic drops Systemic absorption, ———headache, nervousness & trouble sleeping Rebound congestion

Phenylephrine Synthetic, direct Acting, mainly α1 Increases both syst. & diast. BP Reflex bradycardia Decongestant (topically or orally) It replaced pseudoephedrine Induces mydriasis

Clonidine α2 agonist used in hypertension Used to reduce opiates, tobacco and & benzodiazepine withdrawal symptoms??? Centrally, presynaptic---- Side effects: lethargy, sedation, constipation & xerostomia Avoid abrupt withdrawal????

Albuterol & Terbutalin Short acting β2 agonists bronchodilation, / metered dose inhaler Acute asthma-----albuterol Terbutaline used as off labeled----uterine relaxation Side effects: tremor, restlessness, apprehension & anxiety, (tachycardia, arrhythmia after oral admin.) MAOIs are cntraindicated???

Salmeterol & formoterol LABAs / β2 agonist Single dose ----- sustained bronchodilation (12 hrs) Salmeterol, delayed onset of action Recommended for combination therapy (+ corticosteroids, e.g. flutecazone, budesonide) Nocturnal asthma LABAS showed increased risk of asthma-related deaths

Merabegron β3 agonist Relaxes detrusor SM & increases bladder capacity Used in overactive bladder Increases BP Increase level of digoxin Inhibits CYP2D6———— D-D interaction e.g. Metoprolol

Indirect Acting Adrenergic Agonists Amphetamine Centrally acting α1 & β1 Increase nonvesicular release of catecholamines Tyramine No therapeutic use Oxidized by MAO MAOIs ??? Mechanism ???

Indirect Acting Adrenergic Agonists, cont. Cocaine Unique local anesthetic Block (Na+/ Cl-)- dependent transporter Enhanced sympathetic activity Prolong duration of action of Epi & NE

Mixed-Action Adrenergic Agonists Ephedrine & Pseudoephedrine Direct & indirect Not a catecholamines, COMT & MAO ????? Absorption, distribution & elimination Syst. & diast. BP Bronchodilation CNS stimulation, FDA??? Pseudoephedrine treat nasal & sinus congestion Pseudoephedrine & methamphetamine